New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Дата публикации: 03-10-2026 13:00:02

When John Ebers was diagnosed with Stage 3 colorectal cancer, he was not given the option of genetic testing, which could have revealed if there were drugs that could attack his cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?	0	8.36	30-09-2026
2	Clinical trial to treat rectal cancer spares major surgery	0	8.49	24-08-2026
3	FDA panel endorses first-of-a-kind cancer blood test from Grail	0	8.8	23-09-2026
4	Biologists identify a cellular pathway that allows colorectal cancer to metastasize	0	6.94	24-09-2026
5	Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working	0	7.97	30-09-2026
6	Everyday DNA damage reveals a hidden weakness in some cancers	0	9.5	28-09-2026
7	Ученые предупредили о позднем выявлении рака кишечника у молодых людей	0	11.46	07-10-2026
8	Laser light enables detection of colorectal cancer biomarker in blood within minutes	0	8.14	25-09-2026
9	KRAS, el 'gen maldito' detrás de uno de cada cinco cánceres	0	10.95	14-09-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 11.89. Источник: www.seattletimes.com.